CD19 and myeloid sarcoma: The ability of CD19+ B cells to secrete IL-10 is greatly reduced as well in patients with MS8, 9, 10, 11, 12, suggesting that the MS-associated inflammatory milieu is at least partly attributable to a defect in IL-10 generation by B lymphocytes.